End-of-day quote
Taipei Exchange
06:00:00 2024-07-15 pm EDT
5-day change
1st Jan Change
305.5
TWD
-0.16%
-10.15%
+49.75%
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
March 29, 2020 at 03:03 pm EDT
Sunmax Biotechnology Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 594.145 million compared to TWD 304.068 million a year ago. Net income was TWD 100.447 million compared to TWD 74.657 million a year ago. Basic earnings per share was TWD 1.84 compared to TWD 1.38 a year ago.
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
May. 14
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 15
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 12
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-10
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-14
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-30
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-13
CI
Sunmax Biotechnology Co., Ltd.(TPEX:4728) added to S&P Global BMI Index
22-09-19
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
22-08-14
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-05-12
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
22-03-30
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
21-11-15
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Half Year Ended June 30, 2021
21-08-15
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
21-05-13
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
21-03-30
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
20-11-12
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
20-08-12
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
20-05-12
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
20-03-29
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019
19-11-12
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019
19-08-13
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019
19-05-14
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018
19-03-21
CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2018
18-11-11
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
SunMax Biotechnology Co., Ltd. is a Taiwan-based company principally engaged in research, development, production and distribution of collagen implants and related products. The Company's major products include collagen, collagen implants, microfiber collagen hemostat, collagen absorbable hemostat pads, healthcare products, as well as medical collagen application equipment. Its products are applied in medical and beauty care industrials. The Company distributes its products principally in Taiwan, Mainland China and other regions.
More about the company
1st Jan change
Capi.
+49.75% 511M +25.83% 46.56B +45.38% 41.67B +0.69% 41.16B +30.52% 32.4B +22.30% 28.18B -6.35% 28.1B +49.25% 14.52B +49.18% 13.74B +3.45% 12.17B
Other Biotechnology & Medical Research
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1